Literature DB >> 25035732

A purple ulcer.

Caleb P Canders1, Jennifer J Weinberg1.   

Abstract

Entities:  

Mesh:

Substances:

Year:  2014        PMID: 25035732      PMCID: PMC4100832          DOI: 10.5811/westjem.2014.4.21531

Source DB:  PubMed          Journal:  West J Emerg Med        ISSN: 1936-900X


× No keyword cloud information.

CASE

A 42-year-old woman presented with a left lower extremity ulcer. Three weeks prior, she had been struck by a motor vehicle and developed bullae on her thigh, the main area of impact. She could not afford to see a primary doctor, and had been applying a low-cost, over-the-counter topical antiseptic solution to the site since the accident. On examination, she had a 26 by 14 centimeter ulcer on her left medial thigh without tenderness, purulence or crepitance. The ulcer was noted to be bright purple (Figure).
Figure

A purple ulcer on the left medial thigh.

DIAGNOSIS

Gentian violet (hexamethylrosaniline), the basis of the gram stain, has been marketed as an antiseptic since the 1890s.1 It was used intravenously in the early 20th century to treat sepsis, until being replaced by penicillin and other oral antibiotics. Its exact mechanism of action is unknown, although it is hypothesized to promote free radical formation, inhibit bacterial protein synthesis, and uncouple oxidative phosphorylation. In vitro studies have demonstrated its effectiveness against gram-positive bacteria and Candida, and clinical studies have shown effectiveness against some skin infections, including methicillin-resistant Staphylococcus aureus (MRSA).2,3 Given its low cost, ready availability, and limited adverse effects, topical gentian violet may be a useful treatment in under-developed parts of the world as the incidence of MRSA and other skin and soft tissue infections increases.
  3 in total

1.  Effect of gentian violet, corticosteroid and tar preparations in Staphylococcus-aureus-colonized atopic eczema.

Authors:  K Brockow; P Grabenhorst; D Abeck; B Traupe; J Ring; U Hoppe; F Wolf
Journal:  Dermatology       Date:  1999       Impact factor: 5.366

Review 2.  Effectiveness of gentian violet and similar products commonly used to treat pyodermas.

Authors:  Ricardo L Berrios; Jack L Arbiser
Journal:  Dermatol Clin       Date:  2011-01       Impact factor: 3.478

Review 3.  Gentian violet: a 19th century drug re-emerges in the 21st century.

Authors:  Alexander M Maley; Jack L Arbiser
Journal:  Exp Dermatol       Date:  2013-12       Impact factor: 3.960

  3 in total

北京卡尤迪生物科技股份有限公司 © 2022-2023.